Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 18, 2020
Stelis BioSource has started the next phase of its continued investment program.
read more
Monday, November 16, 2020
Moderna announced the DSMB for the Phase 3 study of mRNA-1273 has informed the company the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
read more
Monday, November 16, 2020
TCR2 Therapeutics has established a manufacturing partnership with ElevateBio, to leverage the technical capabilities at ElevateBio BaseCamp, a cell and gene therapy manufacturing facility based in Waltham, MA.
read more
Monday, November 16, 2020
Pharmaron Beijing has acquired 100% of the equity of Absorption Systems for up to US$137.5 million in cash.
read more
Friday, November 13, 2020
Flamma entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury supply chain.
read more
Wednesday, November 11, 2020
Centogene and Fujirebio Europe have entered a partnership to leverage LUMIPULSE G technology for large-scale COVID-19 antigen testing with further deployment in German airports.
read more
Tuesday, November 10, 2020
Novasep is investing €6.5 million to expand capacity & increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site.
read more
Tuesday, November 10, 2020
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China.
read more
Friday, November 06, 2020
Flamma has entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury (remdesivir) supply chain.
read more
Thursday, November 05, 2020
Taysha Gene Therapies and Catalent announced a partnership to support the development and manufacturing of Taysha’s gene therapies at Catalent’s Maryland-based gene therapy facilities.
read more
Thursday, November 05, 2020
Monaghan Medical Corporation (MMC) announced the opening of a new 65,000-square-foot facility that doubles the size of its previous headquarters building.
read more
Thursday, November 05, 2020
Qualigen has signed a contract with WuXi STA for GMP production of AS1411, Qualigen's lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials.
read more
Monday, November 02, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Xediton to develop and commercialize firibastat in Canada.
read more
Monday, November 02, 2020
AB2 Bio and WuXi Biologics have entered into a collaboration to set-up and accelerate commercial-scale manufacturing of Tadekinig alfa, AB2 Bio’s novel recombinant IL-18 binding protein.
read more
Monday, November 02, 2020
Catalent has signed an agreement with Bone Therapeutics to acquire its cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support.
read more